Background. Non-adherence to specific allergen immunotherapy is a major hurdle faced by the allergist, contributing to poor clinical outcomes.
No takes yet. Share an insight, caveat, or question.
Mahesh et al. (2022) studied this question.
Synapse has enriched one closely related paper. Consider it for comparative context: